Optimization of chronic lymphocytic leukemia treatment using game theory
The current strategy of chronic lymphocytic leukemia (CLL) treatment is based on genetic risk factors such as del(17p), TP53 mutations and/or unmutated variant of IGHV genes. Guidelines recommend the usage of targeted drugs, e.g. ibrutinib, in the first line for patients with unfavorable risk factor...
| Published in: | Качественная клиническая практика |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
Izdatelstvo OKI
2021-12-01
|
| Subjects: | |
| Online Access: | https://www.clinvest.ru/jour/article/view/587 |